Pharmaceuticals
Bioresorbable stents withdrawn from European markets, to be available only in clinical registries
08 Apr 2017
23andMe gets FDA nod to sell genetic tests directly to consumers
07 Apr 2017
For the first time the FDA has allowed a company to sell genetic tests for disease risk directly to consumers, which would tell people if they were at risk of developing conditions like Parkinson’s and Alzheimer’s
.webp)
